Day 1 Morning

Dr. Anthony Atala is the Director of Wake Forest Institute for Regenerative Medicine and the Chair of Urology at Wake Forest School of Medicine. He is a practicing surgeon and a researcher in the area of regenerative medicine. His current work focuses on growing new human cells, tissues and organs. He is Editor-in-Chief of Stem Cells-Translational Medicine and Therapeutic Advances in Urology, and serves on the editorial board of 20 journals. He has received the US Congress funded Christopher Columbus Award, World Technology Award in Medicine, Samuel Gross Prize, Barringer Medal by the AAGUS, and Gold Cystoscope award. In 2011 he was elected to the Institute of Medicine of the National Academy of Sciences. Dr. Atala’s work has been included twice in Time magazine’s top 10 medical breakthroughs of the year. Dr. Atala is a member of the American Urological Association, American College of Surgeons, numerous international advisory boards, and is a founding member of the Tissue Engineering and Regenerative Medicine International Society. He was featured in U.S. News & World Report as one of 14 Pioneers of Medical Progress in the 21st Century. Over 10 applications of technologies developed in his laboratory have been used clinically. He is the editor of 12 books, has published over 400 journal articles, and has applied for or received over 200 national and international patents.

Dr. Hollister is a Professor of Biomedical Engineering and Mechanical Engineering at the University of Michigan, where he directs the Scaffold Tissue Engineering Group (STEG). Dr. Hollister and his collaborators have designed and developed a variety of medical devices utilizing 3D printing, an area in which he has worked for 17 years, publishing his first paper in 1997. He and his colleagues first developed an approach for laser sintering for polycaprolactone in 2004. His general research focuses on the design, fabrication and evaluation of biomaterial platform systems for tissue reconstruction. He is a fellow of the American Institute of Biological Engineering. His work on a bioresorbable tracheal splint along with Dr. Glenn Green was published in the New England Journal of Medicine in 2013 and subsequently was given a Popular Mechanics 2013 Breakthrough Innovation Award. This implantation of this 3D printed device to save the lives of three children has also been featured on the Today Show, the New Yorker, USA Today, NPR, Time magazine, Nature, Science, and Popular Mechanics among other media.

Jennifer A. Lewis joined the faculty of the School of Engineering and Applied Sciences and the Wyss Institute for Biologically Inspired Engineering at Harvard University in 2013. Prior to joining Harvard, she held a named professorship and served as Director of the Materials Research Laboratory at University of Illinois. An innovative pioneer, she leads a vibrant research group that develops new materials and printing platforms for fabricating functional, structural, and biological structures and devices. To date, her research has resulted in more than 30 patents (issued and filed) and 150 papers. She has received numerous awards, including the NSF Presidential Faculty Fellow Award, the Langmuir Lecture Award from the American Chemical Society, and the MRS Medal Award. She is a Fellow of the National Academy of Inventors, the American Academy of Arts and Sciences, the American Ceramic Society, the American Physical Society, and the Materials Research Society. Her work on microscale 3D printing was recently highlighted as one of the “10 Breakthrough Technologies” by the MIT Technology Review, while her bioprinting research was named “one of the top 100 science stories” by Discover Magazine. She is a co-founder of two companies, which are commercializing technology from her lab.

Hod Lipson is a professor of engineering at Columbia University in New York, and a co-author of the award-winning bestseller “Fabricated: The New World of 3D printing” (translated to 7 languages). His work on self-aware and self-replicating robots, food printing, and bio-printing has received widespread media coverage including The New York Times, The Wall Street Journal, Newsweek, Time, CNN, and the National Public Radio. Lipson has co-authored over 200 technical papers and speaks frequently at high-profile venues such as TED and the US National Academies. Hod directs the Creative Machines Lab, which pioneers new ways to make machines that create, and machines that are creative. For more information visit http://lipson.mae.cornell.edu.

Mr. Resnick joined NCDMM in September 2008 as Vice President, Chief Technology Officer with over 35 years of manufacturing experience. He assumed President & Executive Director in May 2011 and led the NCDMM to winning the competitive National Additive Manufacturing Innovation Institute contract. Upon award, he also assumed the role of Acting Director of America Makes (formerly known as NAMII) until February 2013 when the new director was appointed. Prior to joining NCDMM, Mr. Resnick served as Chief Technology Officer for both The Ex One Corporation and Extrude Hone where he helped establish Extrude Hone and Ex One as leaders in advanced manufacturing. He holds several patents in manufacturing processes and metrology.Mr. Resnickserves on the Board of Directors of SME and is a Fellow and the member of SME’s International Awards and Recognition Committee. In 2010, Mr. Resnick received the NAMRI/SME “Outstanding Lifetime Service Award.”:He also serves on the Board of Directors of the Louisiana Center for Manufacturing Sciences (LCMS); NIST Smart Machining Consortium; Navy Metalworking Center’s (NMC) Industry Advisory Board; MTConnect® Institute; DoD’s JDMTP Metals Subpanel; and the prestigious International Institution for Production Engineering Research (CIRP). Locally, Mr. Resnick recently joined the Board of Directors for the Central Allegheny Challenger Learning Center (CACLC) in Indiana County and the Westmoreland-Fayette Workforce Investment Board.

Dr. Wei Sun (Ph.D. in Mechanical Engineering, 1992, Drexel University), is currently appointed as Albert Soffa Chair Professor of Mechanical Engineering at Drexel University, USA, and National "Thousand-Talent" Distinguished Professor and Director of Biomanufacturing Research Center at Tsinghua University, China. His research has been on Biofabrication, 3D Bio-Printing, Computer-Aided Tissue Engineering, and Additive Manufacturing. He has received research funding from National Science Foundation (NSF), Defense Advanced Research Projects Agency (DARPA), National Aeronautics and Space Administration (NASA), Chinese Natural Science Foundation (CNSF) and Chinese Ministry of Science and Technology (MOST). He is currently serving Editor-in-Chief for journal Biofabrication, and served as Founding President for International Society of Biofabrication.

Day 1 Afternoon

Amit Bandyopadhyay received his BS in Metallurgical Engineering from Jadavpur University in 1989 (Kolkata, India), MS in Metallurgy from the Indian Institute of Science in 1992 (Bangalore, India) and Ph.D. in Materials Science and Engineering from the University of Texas at Arlington in 1995. He joined the Center for Ceramics Research at Rutgers University for his post-doctoral training in 1995. In 1997, he joined the School of Mechanical and Materials Engineering (MME) at WSU as an Assistant Professor and promoted to an Associate level in 2001 and to the full professor level in 2006. Prof. Bandyopadhyay’s research expertise lies with additive manufacturing of metallic and ceramic materials and their composites towards structural, bio- and piezoelectric materials. Prof. Bandyopadhyay published over 250 technical papers and holds 12 US patents. He has also edited 8 books. His research papers have been cited over 7200 times by various research groups and his current “h” index is 47. Prof. Bandyopadhyay received the CAREER award from the US National Science Foundation and the Young Investigator Program (YIP) Award from the US Office of Naval Research. Prof. Bandyopadhyay is a Fellow of the American Ceramic Society (ACerS), American Society for Materials (ASM International), American Institute for Medical and Biological Engineering (AIMBE), American Association for the Advancement of Science (AAAS) and National Academy of Inventors (NAI).

Dr. Shaochen Chen is a Professor and Vice Chair in the NanoEngineering Departmentat the University of California, San Diego (UCSD). He is a founding co-director of the Biomaterials and Tissue Engineering Center at UCSD. Before joining UCSD, Dr. Chen had been a Professor and a Pearlie D. Henderson Centennial Endowed Faculty Fellow in Engineering at the University of Texas at Austin from 2001 to 2010. Between 2008 and 2010, he served as the Program Director for the Nanomanufacturing Program of NSF. Dr. Chen’s primary research interests include: biomaterials and 3D bioprinting, stem cell and regenerative medicine, tissue engineering, laser and nanomanufacturing. He has published over 100 papers in top journals and 12 book/book chapters. Among his numerous awards, Dr. Chen received the NSF CAREER award,ONR Young Investigator award, and NIH Edward Nagy New Investigator Award. Dr. Chen is a Fellow of AAAS, AIMBE, ASME, SPIE, and ISNM.

Dr. John P. Fisher is the Robert E. Fischell Professor and Chair in the Fischell Department of Bioengineering at the University of Maryland. Dr. Fisher is the Director of the Tissue Engineering and Biomaterials Laboratory and investigates biomaterials, 3D printing, stem cells, and bioreactors for the regeneration of lost tissues, particularly bone, cartilage, vasculature, and skeletal muscle. The lab examines questions related to how biomaterials affect endogenous signaling among embedded cells as well as the interactions between stem cells and host vascularization. Key recent developments include the creation of a modular and scalable bioreactor for cell and tissue culture as well as the fabrication of 3D printed substrates for tissue regeneration. The lab is supported by research grants from NIH, FDA, NSF, NIST, DoD, and other institutions, and has authored over 115 publications, 250 scientific presentations, and 13 patents / patent applications. Dr. Fisher has advised 5 postdoctoral fellows, 17 Ph.D. students, 6 M.S. students, and over 60 undergraduate researchers. In 2012 Dr. Fisher was elected Fellow of the American Institute for Medical and Biological Engineering. In 2015 Dr. Fisher visited the National University of Ireland, Galway as a Fulbright Fellow. Dr. Fisher is currently the Editor-in-Chief of the journal Tissue Engineering, Part B: Reviews, and Continental Chair Elect of the Tissue Engineering and Regenerative Medicine Society International - Americas Chapter.

Dr. Ola L. A. Harrysson joined the ISE Department at North Carolina State University in Raleigh, North Carolina in 2002 after receiving his Ph.D. in Industrial Engineering from the University of Central Florida in Orlando, Florida. Prior to attending the University of Central Florida he was born and raised in Sweden and received his bachelor’s degree in Mechanical Engineering from Dala University. He has been conducting research in Rapid Prototyping and Additive Manufacturing for over 15 years. His main areas of research are medical application of additive manufacturing technologies, custom design and fabrication of orthopedic implants, medical device development, and materials development for Direct Metal Additive Manufacturing technology. Dr. Harrysson is the Co-Director of the Center for Additive Manufacturing and Logistics at NC State University. The Center houses a number of polymer and metal additive manufacturing technologies. Dr. Harrysson is currently a full professor in the Fitts Department of Industrial and Systems Engineering at NC State University and a Fitts Faculty Fellow in Biomedical Manufacturing.

Dr. Ringeisen is Head of the Bioenergy and Biofabrication Section at the U.S. Naval Research Laboratory (NRL). Dr. Ringeisen graduated with a B.S. in chemistry from Wake Forest University in 1994. He then entered graduate school at the University of Wisconsin—Madison to study gas scattering and reactivity at liquid surfaces. He graduated with a PhD in Physical Chemistry in 2000. He then went to NRL for a two year postdoctoral associateship in the Materials Division to study laser deposition of biomaterials. During this postdoctoral position, Dr. Ringeisen performed the first successful laser induced forward transfer printing experiment on a living cell. He was hired as a research chemist at NRL in 2002 and currently maintains an eleven member research group. He holds 12 patents, has published over 60 peer-reviewed research publications and has received research funding from the Department of Energy, the Defense Threat Reduction Agency, the Defense Advanced Research Program Agency, the U.S. Bureau of Engraving and Printing, the Air Force Office of Scientific Research, the Office of Naval Research and the Naval Research Laboratory. His Section focuses on research that cuts across multiple disciplines including materials science, bioengineering, surface chemistry, micro- and molecular biology and environmental science. Our current projects include bioprospecting for energy-relevant microorganisms, microbial fuel cells, layer-by-layer fabrication of 3D tissue constructs for in vitro testing, biofuels and nanocatalysis.

Dr. Albert Shih is Professor in Mechanical Engineering, Biomedical Engineering, and Integrative Systems and Design (ISD) at the University of Michigan. He is the Associate Chair of ISD and Director of the Global Automotive and Manufacturing Engineering Program. He was a manufacturing process development engineer, specialized in advanced grinding, from 1991 to 1998, at Cummins Inc. Dr. Shih’s research area is design and manufacturing. He is a pioneer in biomedical manufacturing, the application of manufacturing technologies to advance the safety, quality, efficiency and speed of healthcare service and biomedical science. He has 9 US patents, a textbook in Machining and Machine Tools, and authored or co-authored over 180 archival journal papers, 90 conference papers in manufacturing and biomedical sciences. Dr. Shih is the Chair of Scientific Committee of the North American Manufacturing Research Institution of the Society of Manufacturing Engineers (NAMRI/SME). He is the recipient of many awards including the Fulbright Scholar, ASME Milton Shaw Manufacturing Research Medal, Society of Automotive Engineers Ralph R. Teetor Educational Award, and Best Paper awards in ASME International Manufacturing Science and Engineering Conference (MSEC), North American Manufacturing Research Conference (NAMRC),International Conference on Frontiers of Design and Manufacturing (ICFDM) and several other manufacturing and healthcare conferences. Dr. Shih is Fellow of both ASME and SME and associate member of CIRP.

Dr. David B. Wallace is currently Vice President of MicroFab Technologies, Inc. He has 35 years of industrial experience in complex fluid flow phenomena, including 30 years in ink jet printing. He has authored over 80 publications and has been awarded 28 patents; received his BSE and MSME from Southern Methodist University and a Ph.D. from the University of Texas at Arlington; is a licensed Professional Engineer; is an Adjunct Faculty member of the Joint Biomedical Engineering Program of the University of Texas (Southwestern, Arlington, and Dallas); is a member of the Industrial Advisory Board for the ME Program at UT Dallas and the BE Program at UT Arlington; is an ad hoc reviewer for several technical societies; and is an ASME fellow.

Dr. Michael J. Yaszemski is the John and Posy Krehbiel Endowed Professor of Orthopedic Surgery and Biomedical Engineering at the Mayo Clinic and director of its Polymeric Biomaterials and Tissue Engineering Laboratory. He is a retired U.S. Air Force Brigadier General and served in the office of the Air Force Surgeon General and the office of the President of the Uniformed Services University of the Health Sciences prior to retiring in 2013. He just completed term as president of the Mayo Clinic medical staff, and had served for 10 years as the Chair of the Spine Surgery Division at Mayo prior to entering the presidential line. He received both Bachelor’s and Master’s degrees in Chemical Engineering from Lehigh University in 1977 and 1978, an M.D. from Georgetown University in 1983 and a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology in 1995. He organized and served as the first chair of the Musculoskeletal Tissue Engineering study section at NIH, and has recently completed a term of service on the Advisory Council of the National Institute of Biomedical Imaging and Bioengineering. He served as Chair of the FDA Center for Devices and Radiologic Health Advisory Committee, and is currently a member of the FDA Science Board. He is a member of the Lehigh University Board of Trustees. His research interests are in the synthesis and characterization of novel degradable polymers for use in bone regeneration, cartilage regeneration, nervous tissue regeneration, and controlled delivery of chemotherapeutic agents to musculoskeletal tumors.

Dr. Kaiming Ye is Professor and Department Chair of Biomedical Engineering at the Binghamton University, State University of New York (SUNY). He was Program Director at NSF before his joining to Binghamton University. He is one of the top most distinguished and accomplished leaders in the field of Medical and Biological Engineering. He is Fellow of the American Institute of Medical and Biological Engineering (AIMBE) and Senior Member of IEEE. His research interests include 3D bioprinting, advanced biomanufacturing, stem cell engineering, regenerative medicine, imaging and vaccine development. He is best known for his creative works in 3D differentiation of human pluripotent stem cells into clinically relevant cell lineages and development of fluorescent nanosensors for continuous glucose monitoring. His research has been continuously supported by NIH, NSF, JDRF, ABI and industries funding. He has chaired and co-chaired a number of international conferences and has been invited to deliver keynote/plenary speech in numerous international and national conferences. He serves as Editor-in-Chief, Executive Editor, Associate Editor, and member of Editorial Boards of 13 journals.

Dr. Lijie Grace Zhang is an associate professor in the Department of Mechanical and Aerospace Engineering, Department of Biomedical Engineering and Department of Medicine at the George Washington University. She obtained her Ph.D. in Biomedical Engineering at Brown University in 2009. Dr. Zhang joined GW in 2010, after finishing her postdoctoral training at Rice University and Harvard Medical School. She is the director of the Bioengineering Laboratory for Nanomedicine and Tissue Engineering at GW. She has received the NIH Director’s New Innovator Award, Young Innovator in Cellular and Molecular Bioengineering, GW SEAS Outstanding Young Researcher Award, John Haddad Young Investigator Award by American Society for Bone and Mineral Research, GWU SEAS Faculty Recognition Award, Early Career Award from the International Journal of Nanomedicine, Ralph E. Powe Junior Faculty Enhancement Award by the Oak Ridge Associated Universities Organization, Joukowsky Family Foundation Outstanding Dissertation Award at Brown and the Sigma Xi Award. Her research interests include nanobiomaterials, 3D bioprinting, complex tissue engineering, stem cell engineering, drug delivery and breast cancer bone metastasis. Dr. Zhang has authored 2 books, over 74 journal papers, book chapters and conference proceedings, 4 patents and has presented her work on over 190 conferences, university and institutes.

Day 2 Morning

LT James Coburn is a senior researcher in the FDA’s Center for Devices and Radiologic Health (CDRH). He began his career in clinically-directed experimental orthopedic research at Brown University. He then built a foundation in tissue engineering through a research fellowship with AbhayPandit at the National University of Ireland, Galway. He is now a principle investigator of collaborative 3D printing-based interdisciplinary research projects in the Office of Science and Engineering Laboratories and a co-chair of the FDA Additive Manufacturing Working Group. His research strives to incorporate patient-based needs and variability, into medical device research and development, especially with regard to 3D printing of innovative medical products.

Dr. Deborah J. Goodings is director of the Division of Civil, Mechanical, and Manufacturing Innovation in the Directorate for Engineering at the National Science Foundation. Goodings is detailed to NSF from her position as Dewberry Chair Professor of Civil Engineering, and Chairman of the Department of Civil, Environmental, and Infrastructure Engineering at George Mason University. Before joining George Mason, Goodings held a faculty appointment in the Department of Civil and Environmental Engineering at the University of Maryland for nearly 30 years. She was recognized by the Transportation Research Board with the Fred Burggraf Award; by the Department of the Army with the Outstanding Civilian Service Medal; by the U.S. Universities Council on Geotechnical Engineering Research with their Distinguished Service Award following her service as its President; and an endowed chair was established in her honor upon her departure from the University of Maryland. Goodings earned her Bachelor’s degree in Civil Engineering at the University of Toronto and her Ph.D. in Geotechnical Engineering at Cambridge University. She is a Fellow of the American Society of Civil Engineers; a Diplomate, Geotechnical Engineering; and a registered professional engineer.

Rosemarie Hunziker, Ph.D. is the Director of the Tissue Engineering/Regenerative Medicine and Biomaterials Programs at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) within the National Institutes of Health (NIH) in the US Department of Health and Human Services (DHHS). In that capacity she has programmatic oversight of discovery and appliedresearch grants. Dr. Hunziker brings a diverse background to this broad sphere of research, including experience in microbiology, immunogenetics and immunochemistry, developmental biology, animal husbandry, molecular biology, stem cell technologies, tissue engineering (most recently in the “tissue chips” programs) and regenerative medicine, biomaterials, and technology transfer. Rosemarie is committed to nurturing discovery science and realizing the practical benefits of the exciting developments at the forefront of cell-based tools and therapies.

Carrie Laurencot, Ph.D. has over 25 years of experience in drug discovery and development in industry, a contract research organization and the federal government. Her expertise includes regulatory affairs and clinical development for anti-cancer therapies, gene and cell therapies, immunotherapies and military medicine. Currently, Dr. Laurencot is the Senior Regulatory Affairs Advisor at the U.S. Army Medical Research Materiel Command where she is responsible for planning, establishing and evaluating long-range regulatory objectives for major programs and projects as well as developing new concepts, interpretations, policies, and procedures that affect medical product development. She collaborates with the FDA senior leadership on strategic initiatives for military medicine. In addition, she serves as a regulatory affairs subject matter expert to the Army Surgeon General’s (TSG) Sponsor’s Representative to the Food and Drug Administration (FDA), to the commanding General of USAMRMC, the USAMRMC Milestone Decision Authority, and to the Commander of the U.S. Army Medical Materiel Development Activity (USAMMDA). She is the primary interface between the Directors of USAMMDA regulatory elements to include the Division of Regulated Activities and Compliance (DRAC) and Clinical Services Support Division (CSSD) and the TSG Sponsor’s Representative to the FDA.

Anne Plant received a PhD in biochemistry from Baylor College of Medicine and has been engaged in research in biophysics, predictive models, and quantitative methods for cell biology. She serves as Chief of the Biosystems and Biomaterials Division at NIST in the Material Measurements Laboratory. She has been on detail at the White House Office of Science and Technology Policy, and is an AIMBE Fellow. NIST is a multidisciplinary organization that is part of the Department of Commerce and is charged with developing measurement technologies and standards that support the success of industry. The Biosystems and Biomaterials Division in collaboration with other scientists at NIST works with the research and industrial community on genomic, imaging, and other methodologies and benchmarking methods that allow rigorous quantification of single cells and cell populations.